Justin K Moran

Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies.

Boris Gorovits, P. Frost, S. Stephens, 2004, Blood.